Abstract:The main target of the current research is designing and synthesizing novel Co(II) complexes derived from 2-hydroxy-5,3-(phenylallylidene)aminobenzoic acid ligand and to enhance comprehension as potential photocatalyst, antibacterial, antifungal, and antioxidants alternatives by means of using density functional theory (DFT) calculations and molecular docking investigation. Thus, 2-hydroxy-5,3-(phenylallylidene)aminobenzoic acid (L1), was prepared by thermal condensation of cinnamaldehyde with 5-aminosalicylic acid in methanol. A series of cobalt(II) complexes with newly synthesized Schiff base ligand and para substituted phenylphenol (L2) corresponding to complex 1, [Co II (L1) 2 (H 2 O) 4 ], and mixed-ligand complexes, 2 and 3, [Co II (L2) 1/2 (L1)(H 2 O) 4/3 ], have been prepared and analysed by FTIR, 1 H NMR, HRMS, PXRD, electrochemical and fluorescence spectral techniques. DFT calculations were utilized to verify the molecular structure, analysis of Frontier Molecular orbitals (FMOs), molecular electrostatic potential (MEP) and reactivity descriptor for complexes 1–3. In vitro experiments were conducted to evaluate the biological properties of the complexes. These findings revealed that the synthesized metal complexes have heightened biological efficacy as related to the unbound ligand. Complex 2 has been observed to show effective antibacterial MIC value against P. aeruginosa (3.81 μg/mL) which is superior to the efficacy of standard drug chloramphenicol used (7.81 μg/mL) while the antifungal activity of complexes was found to be moderate to that of standard nystatin. Complex 2 has also demonstrated strong antioxidant activity (67.7%), which was on par with ascorbic acid used as a reference. Furthermore, in silico antibacterial activities (molecular docking) of the complexes have indicated these to exhibit excellent efficacy with docking score of − 11.1, − 9.8 and − 9.4 KCalmol −1 against target proteins E. coli (PDB ID: 4OPQ), P. aeruginosa, (PDB ID: 6NE0) and S. aureus, (PDB ID: 3Q89), respectively. The photocatalytic behaviour of the Co(II) based complexes has been studied by Buchwald-Hartwig C–N (BHC) and Suzuki Miyura C–C (SMC) cross coupling reactions. Lastly, a correlation between in vitro efficacies with molecular docking data and photocatalytic activity with DFT data was done and analysed.

Green processing and characterization of Novel HETERO-ligand Co(II) complexes with cyanopyridine derivatives: Quantitative structure, Computational assessment, and Biological activity relationship

Design, Spectroscopic Analysis, DFT Calculations, Catalytic Evaluation, and Comprehensive In Silico and In Vitro Bioactivity Studies, Including Molecular Docking, of Novel Co(II) Complexes of 2-Hydroxy-5,3-(phenylallylidene)aminobenzoic Acid

Crystal structure, Hirshfeld surface analysis, molecular modeling, electrochemical properties, and of a novel binuclear Co(II) complex

Green synthesis of nanosized N,N'-bis(1-naphthylidene)-4,4'-diaminodiphenylmethane and its metal (II) complexes and evaluation of their biological activity

Green and Efficient Synthesis, Spectroscopic, Characterization, Antibacterial Activity of Some Selected Transition Metal Complexes of Novel Schiff Base Ligand Derived from 2-amino 5-methyl benzimidazole with 2-bromo Isophthalaldehyde

An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects

Synthesis and Structural Elucidation for New Schiff Base Complexes; Conductance, Conformational, MOE-Docking and Biological Studies

Designing, Characterization, DFT, Biological Effectiveness, and Molecular Docking Analysis of Novel Fe(III), Co(II), and Cu(II) Complexes Based on 4-Hydroxy-2 H -pyrano[3,2- c ]quinoline-2,5(6 H )-dione

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Synthesis, Characterization, Geometric Optimization and Multi-Target Therapeutic Evaluation of New Homoleptic and Heteroleptic Cd(II) Carboxylates

Innovation of some novel complexes based on 1‐(4‐nitrophenyl)‐1H‐1,2,3‐triazol‐4‐yl)methanol ligand: Synthesis, structural elucidation DFT calculation and pharmaceutical studies

An efficient synthesis for Cd(II), Cu(II), and UO 2 (II) complexes with N-ethyl-2-(1-(naphthalen-1-yl)ethylidene)hydrazine-1-carbothioamide under solvent-free condition using ball milling as green protocol

Design, Synthesis, Structural Investigation and Photo Induced Biological Investigations of Co(II), Ni(II) and Cu(II) Complexes Derived from N,O Donor Schiff Bases

Synthesis, Crystal Structure, Theoretical Calculations, Antibacterial Activity, Electrochemical Behavior, and Molecular Docking of Ni(II) and Cu(II) Complexes with Pyridoxal-Semicarbazone

Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal(II) complexes derived from heterocyclic Schiff base ligands

Crystal Structure, Anticancer, and Antimicrobial Evaluation of a Novel Substituted Pyrazole Ligand and Its Co(II), Ni(II), and Zn(II) Complexes

Polymer complexes: LXXIX—synthesis, characterization, geometrical structures, biological activity and molecular docking studies of azo dye complexes

New Fe(III), Co(II), Ni(II), Cu(II), and Zn(II) mixed-ligand complexes: stractural, DFT, biological, and molecular docking studies

Synthesis, Characterisation, Hirshfeld surface analysis, Magnetic susceptibility, DFT calculations, pkCSM profile, and Biological activities of Novel mono‐, di‐, and multinuclear Cobalt (II) complexes

Synthesis, Spectral Characterization, Antimicrobial Activity, DFT Calculations, Molecular Docking and ADME Studies of Novel Schiff Base Co(II), Ni(II), Cu(II) and Zn(II) Complexes Derived from 4‐nitro‐ortho‐phenylenediamine

Novel amide based macrocyclic complexes of Co(II): Synthesis, structural characterization, thermal, DFT, molecular docking studies, in vitro cytotoxic, antimicrobial and antioxidant evaluation